Oscar Health, Inc. (OSCR) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $2.77B | +81.7% |
| 2024 | $1.53B | -18.3% |
| 2023 | $1.87B | +20.0% |
| 2022 | $1.56B | +41.2% |
| 2021 | $1.10B | +33.6% |
| 2020 | $826.33M | +145.5% |
| 2019 | $336.64M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $2.77B | +81.7% |
| 2024 | $1.53B | -18.3% |
| 2023 | $1.87B | +20.0% |
| 2022 | $1.56B | +41.2% |
| 2021 | $1.10B | +33.6% |
| 2020 | $826.33M | +145.5% |
| 2019 | $336.64M | — |